Adial Pharmaceuticals Inc (ADIL)
1.52
+0.11
(+7.80%)
USD |
NASDAQ |
May 17, 16:00
1.52
0.00 (0.00%)
After-Hours: 20:00
Adial Pharmaceuticals Accounts Payable (Quarterly): 0.1033M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.1033M |
September 30, 2023 | 0.0819M |
June 30, 2023 | 0.1117M |
March 31, 2023 | 0.5301M |
December 31, 2022 | 0.2764M |
September 30, 2022 | 0.2782M |
June 30, 2022 | 0.6178M |
March 31, 2022 | 0.4151M |
December 31, 2021 | 0.2862M |
September 30, 2021 | 0.1852M |
June 30, 2021 | 0.4774M |
Date | Value |
---|---|
March 31, 2021 | 0.6374M |
December 31, 2020 | 0.6487M |
September 30, 2020 | 0.2474M |
June 30, 2020 | 0.4424M |
March 31, 2020 | 0.1964M |
December 31, 2019 | 0.1902M |
September 30, 2019 | 0.4751M |
June 30, 2019 | |
March 31, 2019 | 0.3292M |
December 31, 2018 | 0.0997M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.0819M
Minimum
Sep 2023
0.6487M
Maximum
Dec 2020
0.3445M
Average
0.2822M
Median
Accounts Payable (Quarterly) Benchmarks
BioVie Inc | -- |
BioSig Technologies Inc | -- |
Precision BioSciences Inc | 1.136M |
Humacyte Inc | 3.452M |
Monogram Orthopaedics Inc | 1.321M |